Business
Block Listing Return and Total Voting Rights
Block Listing Return and Total Voting Rights.
About this update from Allergy Therapeutics Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 7751L\n Allergy Therapeutics PLC\n 15 January 2021\n \n \n \n \n Allergy Therapeutics plc\n \n \n (\"Allergy Therapeutics\", \"ATL\" or the \"Group\")\n \n \n \n \n \n \n \n \n Block Listing Return and Total Voting Rights\n \n \n \n \n \n \n \n \n \n \n \n Block Listing Return\n \n \n \n \n \n \n \n \n Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, makes the following update on its block listings, pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies.\n \n \n \n \n \n \n \n \n \n \n \n \n Name of applicant:\n \n \n \n \n ALLERGY THERAPEUTICS PLC \n \n \n \n \n \n \n Name of scheme:\n \n \n \n \n Allergy Therapeutics plc 2013 Long Term Incentive Plan \n \n \n \n \n \n \n Period of return:\n \n \n \n \n From:\n \n \n \n \n 2 July 2020 \n \n \n \n \n To:\n \n \n \n \n 15 January 2021\n \n \n \n \n \n \n Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission:\n \n \n \n \n 10,000,000 ordinary shares of 0.1p each in the Company admitted to trading on 24 November 2017\n \n \n \n \n \n \n Balance of unallotted securities under scheme(s) from previous return:\n \n \n \n \n 6,831,964\n \n \n \n \n \n \n \n \n \n Plus:\n \n \n \n The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):\n \n \n \n \n - \n \n \n \n \n \n \n Less:\n \n \n \n Number of securities issued/allotted under scheme(s) during period: \n \n \n \n \n 3,506,360\n \n \n \n \n \n \n \n \n \n \n \n \n Equals:\n \n \n \n Balance under scheme(s) not yet issued/allotted at end of period:\n \n \n \n \n 3,325,604\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Name of contact:\n \n \n \n \n Sara Goldsbrough\n \n \n \n \n \n \n Telephone number of contact:\n \n \n \n \n +44 (0) 7966 165719 \n \n \n \n \n \n \n \n \n Total Voting Rights\n \n \n \n \n \n \n \n \n Allergy Therapeutics also announces that \n pursuant to its block admission facility, details of which were announced on 20 November 2017, it has recently issued 928,437 ordinary...